Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma

Published:2013-04-17 Issue:11 Volume:54 Page:2441-2447
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Aoki Kazunari¹,Takahashi Takayuki¹,Tabata Sumie¹,Kurata Masayuki¹,Matsushita Akiko¹,Nagai Kenichi¹,Ishikawa Takayuki¹

Affiliation:

1. Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, Kobe, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.780654

Reference20 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

4. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

5. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study;European Journal of Haematology;2024-07-31

2. Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis;Journal of Hematology;2022-10

3. Impact of therapeutic management and geriatric evaluation on patient of eighty years and older with diffuse large B‐cell lymphoma on survival: A systematic review;European Journal of Haematology;2021-09-21

4. Parameter inference for a stochastic kinetic model of expanded polyglutamine proteins;Biometrics;2021-05-06

5. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review;Critical Reviews in Oncology/Hematology;2021-04